Oramed Pharmaceuticals - ORMP Company profit before taxes, interest and amortization
The fate of Oramed Pharmaceuticals (ORMP) is tied to FDA decisions regarding capsule insulin, which determines capital inflows. Revenues are based on investments and partnerships in the field of oral proteins. The robotization of dosing lines reduces manual labor costs. Total EBITDA for the period demonstrates operational resilience, while 0.00 represents the current metric.
Summary analytical data breakdowns for Oramed Pharmaceuticals Inc. (ORMP)
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Oramed Pharmaceuticals|ORMP - Long-Term Debt to Equity|Current Liabilities to Capital Oramed|ORMP - Company Debts|Debt to Net Assets Ratio Oramed Pharmaceuticals|ORMP - Company Long-Term Debts|Company Short-Term Debts Oramed Pharmaceuticals|Quick Liquidity Indicator oramed.com
- earnings and market ratios statistics:
ORMP - Net Profit|Expected Net Profit Oramed Pharmaceuticals|ORMP - P/E Multiple|Price to Future Earnings Ratio Oramed|ORMP - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Oramed Pharmaceuticals|ORMP - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Oramed Pharmaceuticals|ORMP - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months oramed.com|ORMP - Earnings growth in current year|Earnings growth forecast for next year Oramed Pharmaceuticals
Analysis of all company metrics:Oramed Pharmaceuticals
Implementing an innovative oral insulin delivery platform requires colossal expenditures; therefore, operating profit in cash terms serves as a key indicator of the business's ability to generate cash flow before depreciation and interest. Analyzing this metric allows for an assessment of the actual efficiency of patent commercialization, determining the extent to which the current market value of Oramed Pharmaceuticals (ORMP) is justified by the company's fundamental ability to overcome macroeconomic volatility.
Who Oramed Pharmaceuticals competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Galapagos GLPG|ANI Pharmaceuticals Inc (ANIP) - Profit before interest, taxes and amortization|MNKD - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization AMPH (Amphastar Corp)|PCRX: Operating profit EBITDA|ars-pharma.com (SPRY) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Theravance Biopharma, Inc.|Operating profit before deduction of amortization Aquestive Therapeutics Inc (AQST)|Operating profit EBITDA SCPH|TECX - Profit before interest, taxes and amortization|Operating profit EBITDA TNXP (Tonix Pharmaceuticals)|SXTC: Operating profit before amortization|EPRX: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization BHST (BioHarvest Sciences, Inc.)|Invizyne Technologies, Inc. (EXOZ) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ENTX (Entera Bio)|HYFT (MindWalk Holdings) - Operating profit EBITDA|ABVC: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CPIX|Operating profit EBITDA Quantum BioPharma Ltd. (QNTM)|Profit before payment of interest, taxes and amortization FibroGen Corp FGEN|Income before deduction of interest, taxes and amortization TELO|RANI - Profit before payment of interest, taxes and amortization|Synergy CHC Corp (SNYR) - Operating profit before deduction of amortization|RLYB: Operating profit EBITDA|Lexaria Bioscience Corp. (LEXX) - Operating profit EBITDA|PULM (Pulmatrix Corp) - Operating profit EBITDA|Operating profit before deduction of amortization Pheton (PTHL)|Operating profit EBITDA APM|LYRA - Profit before interest, taxes and amortization|Impact BioMedical - Operating profit before deduction of amortization|Operating profit EBITDA TNF Pharmaceuticals Inc. TNFA|YCBD: Operating profit before deduction of amortization|PainReform Corp - Company profit before taxes, interest and amortization|CYTO: Operating profit EBITDA|LIPO - Operating income before deduction of amortization|OPTN (OptiNose) - Operating profit EBITDA|Operating profit before deduction of amortization Pieris Pharmaceuticals Inc (PIRS)|Operating profit EBITDA PROC|Operating profit EBITDA Petros Pharma (PTPI)|Profit before payment of interest, taxes and amortization Qilian International QLI|acelyrin.com - Profit before payment of interest, taxes and amortization|TFFP - Profit before payment of interest, taxes and amortization
